Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women
- PMID: 23350064
- PMCID: PMC3550694
- DOI: 10.1186/2193-1801-1-39
Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women
Abstract
Body mass index (BMI) is an independent risk factor for luminal-type breast cancer in Western populations. However, it is unclear whether the impact of BMI differs according to breast cancer subtype in Japanese populations. We conducted a case-control study with 715 cases and 1430 age- and menopausal status-matched controls to evaluate the associations of BMI and its change (from age 20 years to the current age) with breast cancer risk. We applied conditional logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Tumor subtypes were divided into four subtypes, namely the luminal, luminal/HER2, HER2-rich, and triple-negative subtypes. Current BMI and BMI change were positively associated with postmenopausal breast cancer risk. On stratified analysis by tumor subtype, we observed associations between current BMI and BMI change and postmenopausal breast cancer risk for the luminal subtype, with OR for each 1 kg/m(2) increase in current BMI of 1.14 (95% CI: 1.07 - 1.20) and the corresponding OR of BMI change of 1.16 (1.09 - 1.23) (each P(trend) < 0.001). Additionally, we found the same tendency for the triple-negative subtype, with the OR for a 1 kg/m(2) increase in current BMI of 1.21 (1.05 - 1.39) and that for BMI change of 1.18 (1.02 - 1.36) (P(trend) was 0.008 and 0.024, respectively). In premenopausal women, a suggestive inverse association was observed between BMI change and breast cancer risk for the luminal subtype only, with OR of BMI change of 0.93 (0.87 - 1.00, P(trend) = 0.054). No association was seen between BMI at age 20 years and risk of any tumor subtype. In conclusion, BMI and its change are associated with the risk of both luminal and triple-negative breast cancer among postmenopausal Japanese women. These findings suggest the etiological heterogeneity of breast cancer among tumor subtypes.
Electronic supplementary material: The online version of this article (doi:10.1186/2193-1801-1-39) contains supplementary material, which is available to authorized users.
Similar articles
-
The association between body mass index and immunohistochemical subtypes in breast cancer.Breast. 2017 Apr;32:227-236. doi: 10.1016/j.breast.2016.09.019. Epub 2016 Oct 15. Breast. 2017. PMID: 27756509
-
Association between body mass index and breast cancer intrinsic subtypes in Japanese women.Exp Ther Med. 2012 Sep;4(3):391-396. doi: 10.3892/etm.2012.621. Epub 2012 Jun 25. Exp Ther Med. 2012. PMID: 23181105 Free PMC article.
-
Body mass index and risk of breast cancer molecular subtypes in Korean women: a case-control study.Breast Cancer Res Treat. 2020 Jan;179(2):459-470. doi: 10.1007/s10549-019-05451-1. Epub 2019 Oct 18. Breast Cancer Res Treat. 2020. PMID: 31628583
-
Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.Int J Cancer. 2014 Dec 1;135(11):2678-86. doi: 10.1002/ijc.28912. Epub 2014 Apr 29. Int J Cancer. 2014. PMID: 24752603
-
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x. Breast Cancer Res. 2017. PMID: 28114999 Free PMC article.
Cited by
-
Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):714-24. doi: 10.1158/1055-9965.EPI-13-1023. Epub 2014 Feb 12. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24521995 Free PMC article.
-
Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.Cancer. 2014 May 15;120(10):1548-56. doi: 10.1002/cncr.28601. Epub 2014 Feb 5. Cancer. 2014. PMID: 24500704 Free PMC article.
-
Association between body mass index and clinical characteristics, as well as with management, in Chinese patients with breast cancer.J Int Med Res. 2020 Aug;48(8):300060520949041. doi: 10.1177/0300060520949041. J Int Med Res. 2020. PMID: 32813551 Free PMC article.
-
Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis.Breast Cancer Res Treat. 2024 Feb;203(3):429-447. doi: 10.1007/s10549-023-07139-z. Epub 2023 Oct 26. Breast Cancer Res Treat. 2024. PMID: 37882920
-
The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answers.Chin J Cancer. 2017 Jan 31;36(1):18. doi: 10.1186/s40880-017-0185-8. Chin J Cancer. 2017. PMID: 28143590 Free PMC article.
References
-
- Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2011;41(1):139–147. doi: 10.1093/jjco/hyq169. - DOI - PubMed
-
- Obesity and overweight. 2011.
-
- Health data. 2010.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous